Priority Date: 01.06.04 (US 20040576271P)

Bispecific fusion antibodies with enhanced serum half-life

  • Application ID: EP12172745
  • Status: APPLICATION DEEMED TO BE WITHDRAWN

Attorneys

no operation time available
1 office
Technology Company
no operation time available
1 office
Technology Company

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 190 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 01.06.2004 - Priority Date (US 20040576271P)
  • 11.06.2014 - Publication A2 (EP2740743)
  • 19.08.2015 - Publication A3 (EP2740743)